Search

Your search keyword '"Receptor, Interferon alpha-beta"' showing total 1,964 results

Search Constraints

Start Over You searched for: Descriptor "Receptor, Interferon alpha-beta" Remove constraint Descriptor: "Receptor, Interferon alpha-beta"
1,964 results on '"Receptor, Interferon alpha-beta"'

Search Results

1. 中国旱獭Ⅰ型干扰素受体β亚基克隆、表达及功能初步鉴定.

2. Innovationen in der Arzneimitteltherapie des systemischen Lupus erythematodes.

3. A randomised, parallel-group, double-blind, placebo-controlled phase 3 study to Determine the effectiveness of the type I interferon receptor antibody, Anifrolumab, In SYstemic sclerosis: DAISY study design and rationale.

4. Safety, Tolerability, Pharmacokinetics, and Immunogenicity of the Anti-IFNAR1 Monoclonal Antibody QX006N: A First-in-Human Single Ascending Dose Study in Healthy Chinese Volunteers.

5. Human IFNAR2 Mutant Generated by CRISPR/Cas9-Induced Exon Skipping Upregulates a Subset of Tonic-Like Interferon-Stimulated Genes Upon IFNβ Stimulation

6. Type I interferon receptor signalling deficiency results in dysregulated innate immune responses to SARS‐CoV‐2 in mice

7. The infectivity and pathogenicity of hepatitis A virus live-attenuated vaccine strain H2 in type I interferon receptor-deficient mice

8. An evaluation of anifrolumab for use in adults with systemic lupus erythematosus

9. PLCG2 and IFNAR1: The Potential Biomarkers Mediated by Immune Infiltration and Osteoclast Differentiation of Ankylosing Spondylitis in the Peripheral Blood.

10. Ceftazidime reduces cellular Skp2 to promote type-I interferon activity.

11. Macrophage Depletion Reactivates Fecal Virus Shedding following Resolution of Acute Hepatitis A in

12. Ifnar gene variants influence gut microbial production of palmitoleic acid and host immune responses to tuberculosis

13. Self-guarding of MORC3 enables virulence factor-triggered immunity

14. A Case of Autosomal Recessive Interferon Alpha/Beta Receptor Alpha Chain (IFNAR1) Deficiency with Severe COVID-19

15. Antiviral activity and mechanism of the antifungal drug, anidulafungin, suggesting its potential to promote treatment of viral diseases

16. Increased Type I interferon signaling and brain endothelial barrier dysfunction in an experimental model of Alzheimer’s disease

17. TRAF3 enhances type I interferon receptor signaling in T cells by modulating the phosphatase PTPN22

18. Influence of Zika virus 3'-end sequence and nonstructural protein evolution on the viral replication competence and virulence

19. Type I interferon receptor subunit 1 deletion attenuates experimental abdominal aortic aneurysm formation

20. Type I interferon receptor (

21. The Th1/Tfh-like biased responses elicited by the rASP-1 innate adjuvant are dependent on TRIF and Type I IFN receptor pathways

22. Genetic and chemical inhibition of IRF5 suppresses pre-existing mouse lupus-like disease

23. Pathological and immunological characterization of bluetongue virus serotype 1 infection in type I interferons blocked immunocompetent adult mice

24. Type I IFN signaling limits hemorrhage-like disease after infection with Japanese encephalitis virus through modulating a prerequisite infection of CD11b+Ly-6C+ monocytes

25. Intact Type I Interferon Receptor Signaling Prevents Hepatocellular Necrosis but Not Encephalitis in a Dose-Dependent Manner in Rift Valley Fever Virus Infected Mice

26. IFNAR2 relevance in the clinical outcome of individuals with severe COVID-19

27. The ZCCHC14/TENT4 complex is required for hepatitis A virus RNA synthesis

28. Interferon-gamma inducible protein 16 and type I interferon receptors expression in experimental apical periodontitis induced in wild-type mice

29. Susceptibility of Type I Interferon Receptor Knock-Out Mice to Heartland Bandavirus (HRTV) Infection and Efficacy of Favipiravir and Ribavirin in the Treatment of the Mice Infected with HRTV

31. A loss-of-function IFNAR1 allele in Polynesia underlies severe viral diseases in homozygotes

32. IFN-β, but not IFN-α, is Responsible for the Pro-Bacterial Effect of Type I Interferon

33. Integrative genomics analysis reveals a 21q22.11 locus contributing risk to COVID-19

34. Critical role of interferons in gastrointestinal injury repair

35. TRIM10 binds to IFN‐α/β receptor 1 to negatively regulate type I IFN signal transduction

36. Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19

37. Immune response to dermatomyositis-specific autoantigen, transcriptional intermediary factor 1γ can result in experimental myositis

38. Slow viral propagation during initial phase of infection leads to viral persistence in mice

39. Exposure–response analysis for selection of optimal dosage regimen of anifrolumab in patients with systemic lupus erythematosus

40. Ubiquitin-Specific Protease 6 Functions as a Tumor Suppressor in Ewing Sarcoma through Immune Activation

41. STING Activated Tumor-Intrinsic Type I Interferon Signaling Promotes CXCR3 Dependent Antitumor Immunity in Pancreatic Cancer

42. Null IFNAR1 and IFNAR2 alleles are surprisingly common in the Pacific and Arctic

43. Inherited IFNAR1 Deficiency in a Child with Both Critical COVID-19 Pneumonia and Multisystem Inflammatory Syndrome

44. Noncognate Signals Drive Enhanced Effector CD8(+) T Cell Responses through an IFNAR1-Dependent Pathway after Infection with the Prototypic Vaccine, 0ΔNLS, against Herpes Simplex Virus 1

45. Molecular and Structural Basis of Receptor Binding and Signaling of a Fish Type I IFN with Three Disulfide Bonds

46. Excessive negative regulation of type I interferon disrupts viral control in individuals with Down syndrome

47. Manipulation of autophagy by SARS-CoV-2 proteins

48. Type I interferon remodels lysosome function and modifies intestinal epithelial defense

49. Type I interferon signaling limits viral vector priming of CD8 + T cells during initiation of vitiligo and melanoma immunotherapy

50. Enhanced effect of modified Zika virus E antigen on the immunogenicity of DNA vaccine

Catalog

Books, media, physical & digital resources